Evidence map›Paper›PMID 28148735›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2017

Sequence and Phylogenetic Analysis of the Untranslated Promoter Regions for

Veron Ramsuran, Pedro G Hernández-Sanchez, Colm O'hUigin, Gaurav Sharma, Niamh Spence, Danillo G Augusto, Xiaojiang Gao, Christian A García-Sepúlveda, Gurvinder Kaur, Narinder K Mehra and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Monalizumab: inhibiting the novel immune checkpoint NKG2A.Journal for immunotherapy of cancer · 2019
    Review
  14. Article
  15. Long Noncoding RNACells · 2019
    Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 5 countries.

Veron RamsuranCancer and Inflammation Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702.
Pedro G Hernández-SanchezCancer and Inflammation Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702.ORCID 0000-0001-6094-2575
Colm O'hUiginCancer and Inflammation Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702.
Gaurav SharmaDepartment of Transplant Immunology and Immunogenetics, All India Institute of Medical Sciences, New Delhi 110029, India.ORCID 0000-0003-2237-0902
Niamh SpenceCancer and Inflammation Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702.ORCID 0000-0002-5191-3614
Danillo G AugustoLaboratório de Genética Molecular Humana, Departamento de Genética, Universidade Federal do Paraná, Curitiba, CEP 81531-980, Brazil.
Xiaojiang GaoCancer and Inflammation Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702.
Christian A García-SepúlvedaLaboratorio de Genómica Viral y Humana, Facultad de Medicina de la Universidad Autónoma de San Luis Potosi, 78210 San Luis Potosi, Mexico.ORCID 0000-0002-1169-7857
Gurvinder KaurDepartment of Transplant Immunology and Immunogenetics, All India Institute of Medical Sciences, New Delhi 110029, India.ORCID 0000-0002-1319-7012
Narinder K MehraDepartment of Transplant Immunology and Immunogenetics, All India Institute of Medical Sciences, New Delhi 110029, India.ORCID 0000-0003-2682-7471
Mary CarringtonCancer and Inflammation Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702; carringm@mail.nih.gov.ORCID 0000-0002-2692-2180
Leidos (United States) · USImmungenetics (Germany) · DEAutonomous University of San Luis Potosí · MXUniversidade Federal do Paraná · BR

Funding

LICI Microbiome and Genetics CoreZICBC011237 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI OHUIGIN, COLM · 2009 to 2025
$28.3M
INCIDENCE OF HIV INFECTIONS IN A COHORT OF IV DRUG USERSR01DA012568 · NIDA · JOHNS HOPKINS UNIVERSITY · PI MEHTA, SHRUTI H · 1999 to 2017
$15.5M
THE NATURAL HISTORY OF HIV INFECTION AMONG DRUG USERSR01DA004334 · NIDA · JOHNS HOPKINS UNIVERSITY · PI KIRK, GREGORY D · 1987 to 2011
$7.6M
CCR NIH HHS HHSN261200800001CNCI NIH HHS HHSN261200800001ENCI NIH HHS N02 CP055504NIDA NIH HHS R01 DA004334NIDA NIH HHS R01 DA012568
6 · The paper itself

Abstract

Polymorphisms located within the

Indexed as

AllelesBase SequenceCell LineGenotypeHLA-A AntigensHLA-B AntigensHLA-C AntigensHumansMolecular Sequence DataPhylogenyPolymorphism, GeneticPromoter Regions, GeneticSequence Analysis, DNAHLA-A AntigensHLA-B AntigensHLA-C Antigens

Identifiers

PMID28148735
PMCPMC5340644
OpenAlexW2584078224

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.